What “unapproved therapeutic goods” means in Australia

The term “unapproved therapeutic goods” is commonly used in Australia, particularly in relation to products like medicinal cannabis and certain vaping products. At first glance, the wording can be confusing and may suggest that a product is unsafe or unregulated.

In reality, the term has a very specific regulatory meaning.

What “unapproved” actually refers to

In Australia, approved therapeutic goods are those listed on the Australian Register of Therapeutic Goods (ARTG) for general supply.

Unapproved therapeutic goods are not included on this register.

This does not mean they are unregulated. Instead, it means they are accessed through specific pathways rather than being widely available.

How unapproved goods are accessed

Unapproved therapeutic goods can be supplied through regulated pathways such as:

• the Special Access Scheme
• the Authorised Prescriber framework

These pathways are designed to ensure that access occurs within a controlled and documented system.

For a broader overview of how access works, see Is medicinal cannabis legal in Australia?

Why these pathways exist

These pathways exist to allow access in situations where products are not available through standard approval processes.

They ensure that:

• access is monitored
• decisions are documented
• supply remains controlled

This approach is used across a range of therapeutic goods, not just vaping or medicinal cannabis.

Why the terminology can cause confusion

The word “unapproved” can be misleading because it is often interpreted as meaning “not allowed” or “not safe.”

In a regulatory context, it simply describes how a product is classified within the system.

Understanding this distinction is important for making sense of how access works in Australia.

How this affects visibility and information

Because unapproved goods are subject to stricter controls, there are also limitations on how they can be:

• advertised
• described
• displayed

This is one of the reasons why information about these products can feel limited or indirect.

Final perspective

“Unapproved therapeutic goods” is a regulatory classification, not a judgement.

It reflects how a product is accessed within the Australian system, not its inherent quality or suitability.

Understanding this helps clarify why certain products are handled differently from standard consumer goods.